Cardiovascular risk assessment in patients with diabetes
- PMID: 28435446
- PMCID: PMC5397821
- DOI: 10.1186/s13098-017-0225-1
Cardiovascular risk assessment in patients with diabetes
Erratum in
-
Erratum to: Cardiovascular risk assessment in patients with diabetes.Diabetol Metab Syndr. 2017 Sep 19;9:70. doi: 10.1186/s13098-017-0270-9. eCollection 2017. Diabetol Metab Syndr. 2017. PMID: 28932289 Free PMC article.
Abstract
Although patients with diabetes have 2 to 4 times increased risk of cardiovascular morbidity and mortality than individuals without diabetes, recent studies indicate that a significant part of patients are in a lower cardiovascular risk category. Men younger than 35 years, women younger than 45 years, patients with diabetes duration of less than 10 years without other risk factors have a much lower risk than patients who have traditional cardiovascular risk factors, and subclinical or established coronary artery disease (CAD). These patients are not risk equivalent as stated in previous studies. On the contrary, when in the presence of traditional risk factors or evidence of subclinical coronary disease (e.g. high coronary calcium score), the coronary risk is much increased and patients may be classified at a higher-risk category. Recent guidelines do not anymore consider diabetes as a CAD risk equivalent and recommend cardiovascular risk stratification for primary prevention. Stratification of diabetic patients improves accuracy in prediction of subclinical CAD, silent ischemia and future cardiovascular events. Stratification also discriminates higher from lower risk patients who may need intensive statin or aspirin prevention, while avoiding overtreatment in lower risk cases. It may also allow the clinician to decide whether to intensify risk reduction actions through specific newer drugs for glucose control such as SGLT-2 inhibitors or GLP-1 agonists, which recently have shown additional cardiovascular protector effect. This review addresses the assessment of cardiovascular disease risk using traditional and non-traditional cardiovascular risk factors. It also reviews the use of risk calculators and new reclassification tools, focusing on the detection of subclinical atherosclerosis as well as silent ischemia in the asymptomatic patients with diabetes.
Keywords: Cardiovascular disease; Risk assessment; Risk factors; Risk stratification; Type 2 diabetes.
Similar articles
-
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: A Systematic Evidence Report for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 17-05225-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 17-05225-EF-1. PMID: 30234933 Free Books & Documents. Review.
-
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM).Diabetol Metab Syndr. 2017 Jul 14;9:53. doi: 10.1186/s13098-017-0251-z. eCollection 2017. Diabetol Metab Syndr. 2017. PMID: 28725272 Free PMC article. Review.
-
Critical appraisal of inflammatory markers in cardiovascular risk stratification.Crit Rev Clin Lab Sci. 2014 Oct;51(5):263-79. doi: 10.3109/10408363.2014.913549. Epub 2014 Jun 11. Crit Rev Clin Lab Sci. 2014. PMID: 24918900 Review.
-
Performance of Coronary Artery Calcium Testing in Patients With Severe Psoriasis: Risk Assessment and Reclassification Potential in a Low Cardiovascular Risk Population.Actas Dermosifiliogr. 2022 Sep;113(8):773-780. doi: 10.1016/j.ad.2022.04.013. Epub 2022 May 4. Actas Dermosifiliogr. 2022. PMID: 35523308 English, Spanish.
-
The Ankle Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction in Asymptomatic Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Sep. Report No.: 12-05162-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Sep. Report No.: 12-05162-EF-1. PMID: 24156115 Free Books & Documents. Review.
Cited by
-
Advancing a causal role of type 2 diabetes and its components in developing macro- and microvascular complications via genetic studies.Diabet Med. 2022 Dec;39(12):e14982. doi: 10.1111/dme.14982. Epub 2022 Oct 31. Diabet Med. 2022. PMID: 36256488 Free PMC article. Review.
-
Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management: consensus statement of the Korean Society for the Study of obesity, Korean Diabetes Association, and Korean Society of Hypertension.Clin Hypertens. 2022 Jun 1;28(1):26. doi: 10.1186/s40885-022-00207-4. Clin Hypertens. 2022. PMID: 35642007 Free PMC article. Review.
-
Prevalence and Incidence Rate of Diabetes, Pre-diabetes, Uncontrolled Diabetes, and Their Predictors in the Adult Population in Southeastern Iran: Findings From KERCADR Study.Front Public Health. 2021 Nov 1;9:611652. doi: 10.3389/fpubh.2021.611652. eCollection 2021. Front Public Health. 2021. PMID: 34790639 Free PMC article.
-
Falls and Fractures in Diabetes-More than Bone Fragility.Curr Osteoporos Rep. 2019 Jun;17(3):147-156. doi: 10.1007/s11914-019-00513-1. Curr Osteoporos Rep. 2019. PMID: 30915638 Review.
-
The Impact of Flash Glucose Monitoring on Markers of Glycaemic Control and Patient Satisfaction in Type 2 Diabetes.Cureus. 2021 Jun 28;13(6):e16007. doi: 10.7759/cureus.16007. eCollection 2021 Jun. Cureus. 2021. PMID: 34354874 Free PMC article.
References
-
- Emerging Risk Factors C. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi: 10.1016/S0140-6736(10)60484-9. - DOI - PMC - PubMed
-
- Organization WH. Diabetes. Fact Sheet N312 2014. http://www.who.int/mediacentre/factsheets/fs312/en/%5D. Accessed Nov 2014.
-
- Organization TWh. The 2016 Global Report on Diabetes. 2016. http://www.who.int/entity/diabetes/global-report/en/index.html. Accessed 6 July 2016.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous